Febenex 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks, tophi formation, and kidney complications associated with elevated uric acid. Febenex 40 is typically prescribed for patients who are intolerant to or inadequately managed by allopurinol. It is important to take this medication exactly as directed by a healthcare professional, usually once daily, with or without food. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities, so regular monitoring of liver function tests is recommended during treatment. Patients should inform their doctor of any history of cardiovascular disease, as Febuxostat may increase the risk of heart-related events. Adequate hydration is advised to prevent kidney stones. Febenex 40 should not be used in patients with severe liver impairment or during pregnancy and breastfeeding unless specifically advised by a physician. Always consult a healthcare provider before starting or stopping this medication to ensure safe and effective use.